Amanta Healthcare Limited Announces Resignation of Senior Management Personnel

1 min read     Updated on 16 Apr 2026, 08:58 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Amanta Healthcare Limited announced the resignation of Shri Vimal Shrimali, AVP – HR & ADMIN, effective April 16, 2026, due to personal reasons. The company has notified stock exchanges BSE and NSE about this senior management change in compliance with SEBI regulations. Shrimali expressed willingness to assist with transition processes for smooth handover of responsibilities.

powered bylight_fuzz_icon
37898907

*this image is generated using AI for illustrative purposes only.

Amanta Healthcare Limited has announced the resignation of a senior management personnel, informing stock exchanges about the departure of Shri Vimal Shrimali from his position as Assistant Vice President – HR & ADMIN. The company made this disclosure in compliance with regulatory requirements under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Resignation Details

The resignation becomes effective from the close of business hours on April 16, 2026. According to the company's regulatory filing, Shrimali tendered his resignation citing personal reasons for his departure from the senior management position.

Parameter: Details
Name of Personnel: Shri Vimal Shrimali
Position: AVP – HR & ADMIN
Reason for Change: Resignation due to personal reason
Effective Date: April 16, 2026
Status: Senior Management Personnel

Regulatory Compliance

Amanta Healthcare Limited notified both BSE Limited and National Stock Exchange of India Limited about this senior management change as mandated under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The company provided all required details as per Schedule III of the regulations.

In his resignation letter dated April 10, 2026, Shrimali mentioned his desire to resign from his present role for future advancement and better opportunities. He expressed his availability for any transition handover processes to ensure smooth operations.

Company Acknowledgment

The company has formally acknowledged Shrimali's resignation and confirmed his relief from duties effective from the specified date. Amanta Healthcare Limited's Company Secretary and Compliance Officer, Nikhita Dinodia, signed the regulatory disclosure documents submitted to the stock exchanges.

The resignation represents a change in the senior management structure of the healthcare company, which maintains its registered and corporate office at Shaligram Corporates, Ambli, Ahmedabad, Gujarat.

Historical Stock Returns for Amanta Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+0.91%+22.46%+33.24%+2.27%-8.40%-8.40%

How will Amanta Healthcare's HR strategy and employee retention be affected by this senior management departure?

What timeline does the company have for appointing a replacement AVP for HR & ADMIN operations?

Could this resignation signal broader organizational changes or restructuring within Amanta Healthcare's management team?

Amanta Healthcare Completes Analyst Meeting and Site Visit at Kheda Facility

1 min read     Updated on 09 Apr 2026, 10:29 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Amanta Healthcare Limited has successfully completed its scheduled analyst and institutional investor meeting on April 7, 2026, at its Kheda, Gujarat facility. The meeting included group discussions and site visits, with company officials sharing only publicly available information while ensuring no Unpublished Price Sensitive Information was disclosed, maintaining full compliance with SEBI regulations.

powered bylight_fuzz_icon
36699036

*this image is generated using AI for illustrative purposes only.

Amanta Healthcare Limited has successfully completed its scheduled meeting with analysts and institutional investors, following through on its commitment to stakeholder engagement and regulatory compliance. The company has formally notified stock exchanges about the outcome of this interaction as part of its ongoing transparency initiatives.

Meeting Execution and Outcome

The company successfully conducted the comprehensive meeting with analysts and institutional investors on April 7, 2026, as previously scheduled. The meeting took place at Kheda, Gujarat, featuring both group discussions and a site visit that provided participants with firsthand insights into the company's operations.

Parameter: Details
Date: Tuesday, April 7, 2026
Venue: Kheda, Gujarat
Format: Group Meeting - In person
Activities: Site Visit
Interaction Type: Analysts / Institutional Investors

Regulatory Compliance and Information Sharing

The meeting outcome notification was submitted pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, demonstrating the company's adherence to regulatory frameworks. This notification was made in reference to the earlier intimation dated April 2, 2026.

During the interaction, company officials maintained strict compliance with insider trading regulations. The company has specifically confirmed that only publicly available information was shared during the meeting, with no Unpublished Price Sensitive Information (UPSI) being discussed or disclosed to participants.

Corporate Governance and Communication

The outcome notification was signed by Nikhita Dinodia, Company Secretary and Compliance Officer, with digital signature authentication dated April 9, 2026. This demonstrates proper corporate governance protocols and authorized communication channels for regulatory disclosures.

The company maintains its registered and corporate office at 8th Floor, Shaligram Corporates, CJ Marg, Ambli, Ahmedabad, Gujarat, with established communication channels including dedicated telephone and email contact points for stakeholder engagement.

Historical Stock Returns for Amanta Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+0.91%+22.46%+33.24%+2.27%-8.40%-8.40%

What strategic initiatives or expansion plans might Amanta Healthcare announce following this investor engagement at their Gujarat facility?

How could the insights gathered from this site visit influence institutional investors' positioning in Amanta Healthcare's stock?

Will Amanta Healthcare schedule similar investor meetings at other operational locations to showcase their broader manufacturing capabilities?

More News on Amanta Healthcare

1 Year Returns:-8.40%